Research summary
Human diseases often begin with small changes within our cells—changes that disrupt normal cellular function. Molecular medicine focuses on understanding how these changes contribute to the development and progression of disease in order to identify new cellular pathways that can be targeted with drugs.
As Canada Research Chair in Molecular Medicine, Dr. Jason Dyck aims to better understand the metabolic changes that occur during heart failure. He and his research team are developing approaches to target the pathways involved in heart failure, identifying new drug targets, and advancing treatments to clinical studies. By improving the molecular understanding of heart failure, Dyck’s research could help millions of people around the world who suffer from this condition.